(RTTNews) - Candel Therapeutics, Inc. (CADL) announced the pricing of an underwritten public offering of 10,000,001 shares at $6 per share and pre-funded warrants to purchase up to an aggregate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback